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after myocardial infarction (MI)9 and coronary artery by-
pass grafting (CABG) surgery10,11 and an atypical clinical 
presentation6, especially below 55 years of age12,13. Due to 
the atypical clinical presentation, women with CAD are 
often under-diagnosed6,14,15. The most obvious explanation 
for the gender-related differences in clinical characteris-
tics is the cardioprotective effect of female sex hormones 
(estrogens). 
Stress is a physiological response to challenges from 
various stressors and the key element in stress response 
is the activation of the HPA axis16,17. Secretion of cortico-
tropin releasing hormone (CRH) from the hypothalamus 
The relationship between psychological stress and car-
diovascular diseases is well established in scientifi c lit-
erature and epidemiological data1–4. The mechanism of the 
negative effect of stress can be indirect, via negative be-
havioral mechanisms like smoking or an unhealthy diet, 
or direct via pathological mechanisms involving the au-
tonomous nervous system and the hypothalamic-pitu-
itary-adrenal (HPA) axis5. 
Gender is a very important factor in the development 
of cardiovascular disease – men with coronary artery dis-
ease (CAD) are 7–10 years younger than females6, while 
women tend to have more risk factors7,8, higher mortality 
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A B S T R A C T 
To explore sex differences in cardiovascular function under stress, we analyzed plasma levels of glucose, C-reactive 
protein (CRP), uric acid and cholesterol in male, female and ovariectomized rats under acute and chronic stress. Glucose 
tolerance test (GTT) was performed in all rats before any stress was performed, as well as later in the chronic stress ex-
periment. GTT in control animals showed the same trend as in chronically stressed. Male rats showed the highest plasma 
level of glucose and uric acid upon acute stress in comparison between the other two groups. Ovariectomized rats reached 
the highest concentration of plasma cholesterol during acute and chronic stress, respectively and also the highest plasma 
concentration of CRP during acute stress. Stress, as a risk factor of metabolic syndrome, affected biochemical parameters 
in males upon acute more than upon chronic stress, but the opposite was observed in female rats. Gender differences sup-
ported by ovariectomy show that stress managing could be affected by sexual hormones.
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stimulates the anterior pituitary gland via the CRH-R1 
and CRH-R2 receptors to produce corticotropin (ACTH), 
which in turn stimulates the adrenal cortex to secrete 
corticosteroids18,19. Another important element of the 
stress response is the sympathoadrenal activation, which 
results in the release of catecholamines20. Glucocorticoids 
provide a link between the HPA axis and sympathetic ac-
tivation by acting as transcriptional activators of phenyl-
ethanolamine N-methyltransferase (PNMT), which syn-
thesizes epinephrine21–23. 
Stress can be either acute or chronic, and various ani-
mal models of stress have been explored (footshock, elec-
tric shocks, forced swimming, restraint etc.). Single and 
repeated exposures to restraint stress induce deregulation 
of the resting activity of the HPA axis24, resulting in in-
creased resting corticosterone levels25–27. The transcrip-
tome in the adrenal medulla is very different after acute 
and chronic stress, with the biggest changes happening in 
transcripts related to growth factors, apoptosis, neurose-
cretion, structural proteins, cytokines and chemokines28. 
Catecholamines, most importantly epinephrine and 
norepinephrine, act through various adrenergic receptors 
on target organs. Gender differences were found in sym-
pathoadrenal activity in rats before and after footshock 
stress29 and also in diabetic rat models30. Similar experi-
ments on female rats found higher values of corticosterone 
in females than males and also demonstrated the impor-
tance of the estrous cycle on observed adrenergic remodel-
ing, which implies the mediation of sex hormones31. 
Women in menopause experience an increase in total 
cholesterol, LDL and lipoprotein levels compared to pre-
menopausal women without estrogens defi ciencies32. Since 
estrogens are important in controlling food intake, energy 
expenditure, the regulation of insulin secretion in pancre-
atic islet β-cells and the protection from β-cell failure, es-
trogens defi ciency can contribute to the development of 
metabolic syndrome, obesity and diabetes33,34. Diabetic 
women also seem to have a higher mortality from cardio-
vascular diseases than men suffering from diabetes35,36.
Infl ammation has a role in the development of cardio-
vascular disease, so measurement of C-reactive protein 
can serve as a marker of infl ammation and can be used to 
improve the prediction of this risk37.
There has been reported a relation between plasma 
uric acid levels and cardiovascular conditions, such as hy-
pertension, metabolic syndrome, coronary artery disease, 
cerebrovascular disease, vascular dementia, preeclampsia 
and kidney disease38,39.
Estrogens protect against cardiovascular disease in 
women through effects on the vascular wall and liver. In 
females, synthesis of estrogens starts in theca interna cells 
in the ovary, by the synthesis of androstenedione from 
cholesterol40.
Due to the complex association of glucose regulation, 
lipid metabolism, uric acid metabolism, infl ammatory re-
sponse and steroid sex hormones, we investigated the ma-
jor biochemical parameters in this sophisticated biochem-
ical puzzle upon the conditions of acute and chronic stress.
Materials and Methods
Animals
Four-month-old Sprague Dawley rats (N=69) were 
used. One group of female rats (N=25) were ovariecto-
mized at three months and included in the experiment 
when they were four months old. Animals were housed in 
standard cages at room temperature with natural day and 
night exchange except for the period of chronic stress when 
lights were on during the night (18:00–09:00). Standard 
laboratory food and tap water were available at all time 
except for 24 hours before GTT when food was removed 
from the cages. Body weights of all rats were measured 
weekly. During the experiments the animals were han-
dled in accordance with the Croatian law on animal wel-
fare. This study was approved by Ethical Committee of 
School of Medicine Osijek. Animals were divided into fol-
lowing groups: 19 animals in chronic stress group, 26 
animals in acute stress group and 24 animals in a control 
group. 
Glucose tolerance test and biochemical analyses
Glucose tolerance test (GTT) was performed one day 
before sacrifi cing, 25% glucose solution was used and 
2mg/g glucose per body weight was injected peritoneal. 
Glucose level was measured at six time points – 0, 15, 30, 
45, 60 and 90 minutes in all animals. OneTouch® Ultra-
Mini® Glucose Meter (Milpitas, CA) was used for all mea-
surements. Blood was drawn directly from the heart and 
plasma was separated by centrifugation. Biochemical 
analyses were performed at the biochemical laboratory of 
University Hospital Centre Osijek for the plasma concen-
tration of glucose, C-reactive protein (CRP), uric acid and 
cholesterol for all animals. CRP, glucose and uric acid 
were measured with SIEMENS Dimension® clinical 
chemistry system Flex® reagent cartridge (Newark, DE). 
Cholesterol was measured with Olympus Diagnostic Sys-
tems Group (Melville, NY).
Ovariectomy
Female rats (N=25) were ovariectomized according to 
protocol (Harlan HUS-QREC-PRD-932, Issue: 01, Revi-
sion 03). Animals were anesthetized with isofl urane and 
placed on the operation table in ventral recumbency. Dor-
sal lumbar area was shaved and the incision was made 
halfway between caudal edge of the ribcage and the base 
of the tail. Another incision was made through the muscle 
bilaterally, after which the ovary and part of the oviduct 
were extracted and removed with a single incision. Re-
maining tissue was placed back into the peritoneal cavity. 
Muscle incision was not sutured, but the skin incision was 
closed by suturing. Postoperatively animals had food and 
tap water available at all time and were held in a clean 
environment under close examination for 72 hours.
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Chronic stress protocol
The following animals: 5 male, 4 ovariectomized and 
10 female rats, were submitted to chronic stress through 
10 days. Chronic stress included stressors in the following 
daily order: lights on overnight (18:00–09:00), 60 minutes 
of cage rotation, food and water deprivation overnight 
(18:00–09:00), 50 minutes of isolation in a cold room at 
+4ºC, 3 minutes of swim stress, lights on with noise over-
night (18:00–09:00; lights on combined with pre-set phone 
alarms in irregular time intervals from 3–15 minutes), 2 
hour exposure to cat ś odor. Some stress sessions were 
repeated two times during 10 days. GTT was performed 
in all animals one day before sacrifi cing. The next day rats 
were sacrifi ced and blood was drawn from the heart for 
the plasma measurements. 
Acute stress protocol
The following animals: 5 male, 11 ovariectomized and 
10 female rats were submitted to acute stress. On the fi rst 
day GTT was performed (food was removed 24 hours be-
fore). On the second day rats were acutely stressed with 3 
hours of isolation in a cold room at +4ºC. Immediately 
upon acute stress rats were sacrifi ced and blood was 
drawn from the heart for plasma measurement. Impact of 
acute stress on plasma biochemical plasma markers must 
be measured immediately after acute stress because bio-
chemical processes of recuperation starts immediately 
after exposure to stress. Therefore, all the animals from 
acute stress group were sacrifi ced immediately after the 
stress was performed.
Control group
The following animals: 4 males, 10 ovariectomized and 
10 female rats were in the control group and were not 
submitted to stress. GTT was performed one day before 
sacrifi cing. Next day rats were sacrifi ced and blood was 
drawn from the heart for the plasma measurement.
Plasma collection
Plasma was collected at the time of sacrifi ce. All ani-
mals were cut through the abdominal wall and blood was 
collected with a syringe from the right ventricle and then 
transferred to 6 mL EDTA tubes. Plasma was separated 
by 5 minutes of centrifugation at 3000 x g.
Statistical analysis
Continuous variables are expressed as median and in-
terquartile range. Due to the sample size and data distri-
bution non-parametric methods (Kruskal-Wallis and 
Mann-Whitney test) were used to compare groups. Statis-
tical signifi cance was defi ned as p<0.05 (two-tailed value). 
The analyses were performed in IBM SPSS Statistics 20 
(SPSS Inc, Chicago, IL).
Results 
Table 1 shows median and interquartile range of glu-
cose, CRP, uric acid and cholesterol levels in male, female 
and ovariectomized animal groups upon no stress, acute 
stress and chronic stress. 
GTT performed in control animals (Figure 1) showed 
a similar trend as in chronically stressed group (Figure 
2). Plasma glucose values upon acute stress were highest 
in male rats (median 12.5 mmol/L; Table 1 and Figure 3). 
Male rats’ glucose values upon acute stress were sig-
nifi cantly higher than values in female rats (p=0.02). 
Upon chronic stress, the differences in glucose values be-
tween male, female and ovariectomized animal group 
were all non-signifi cant.
CRP plasma levels upon acute stress were highest in 
ovariectomized rats (median 1.50 mg/L; Table 1 and Fig-
ure 4) followed by female and male rats (median 1.41 mg/L 
and 1.29 mg/L, respectively; Table 1). Upon chronic stress, 
the CRP levels were higher in male rats and lower in fe-
male and ovariectomized rats (Table 1). The differences 
in CRP levels between male, female and ovariectomized 
animal group upon acute and chronic stress were all sta-
tistically non-signifi cant. 
TABLE 1
MEDIAN AND INTERQUARTILE RANGE OF GLUCOSE, C-REACTIVE PROTEIN (CRP), URIC ACID AND CHOLESTEROL VALUES IN 
MALE, FEMALE AND OVARIECTOMIZED RATS UPON NO STRESS, ACUTE STRESS AND CHRONIC STRESS
Gender Group Glucose (mmol/L) CRP (mg/L) Uric acid (μmol/L) Cholesterol (mmol/L)
Males
Control  12.2 (10.7–17.9) 1.57 (1.32–1.65) 351 (288–420) 2.69 (2.38–3.27)
Acute stress 12.5 (9.5–19.1) 1.29 (1.14–1.40) 220 (165–280) 2.36 (1.96–3.06)
Chronic stress 9.0 (7.0–9.7) 1.49 (1.44–1.56) 205 (192–218) 1.98 (1.84–2.06)
Females 
Control 10.4 (8.6–11.7) 1.43 (0.98–1.57) 259 (221–346) 2.29 (2.05–2.72)
Acute stress   6.6 (4.4–10.7) 1.41 (0.92–1.49) 150 (102–193) 2.68 (2.19–3.11)
Chronic stress   7.9 (6.4–11.5) 1.39 (1.25–1.52) 225 (138–277) 2.07 (1.81–2.35)
Ovariectomized 
Control 12.9 (9.5–14.6) 1.40 (1.22–1.52) 289 (225–394) 2.32 (1.85–2.80)
Acute stress   7.9 (3.1–10.6) 1.50 (1.00–1.73) 153 (143–247) 3.15 (3.10–3.66)
Chronic stress   7.7 (7.3–10.2) 1.47 (1.42–1.57) 214 (202–244) 2.19 (2.08–2.33)
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Fig. 1. Glucose tolerance test – control group. Glucose value is 
expressed in mmol/L.
Fig. 2. Glucose tolerance test upon chronic stress. Glucose value 
is expressed in mmol/L.
Fig. 3. Plasma glucose values compared in all animal groups upon acute (A) and chronic stress (B). MAS – males acutely stressed, 
FAS – females acutely stressed, OAS – ovariectomized acutely stressed, MC – male controls, FC – female controls, OC – ovariecto-
mized controls, MCS – males chronically stressed, FCS – females chronically stressed, OC – ovariectomized chronically stressed.
Fig. 4. Plasma CRP (C-reactive protein) values in all animal groups upon acute (A) and chronic stress (B). MAS – males acutely 
stressed, FAS – females acutely stressed, OAS – ovariectomized acutely stressed, MC – male controls, FC – female controls, OC – 
ovariectomized controls, MCS – males chronically stressed, FCS – females chronically stressed, OC – ovariectomized chronically 
stressed.
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Uric acid plasma levels were lower upon acute stress 
in all three groups when compared to the control group 
(Table 1 and Figure 5). Uric acid levels in male rats upon 
acute stress were signifi cantly higher than the female rats 
values (p=0.04), while the difference between male and 
ovariectomized rats remained non-signifi cant. Uric acid 
values decreased in male rats upon chronic stress and 
increased in female and ovariectomized rats (Table 1). The 
differences in uric acid levels between male, female and 
ovariectomized animal group upon chronic stress were all 
non-signifi cant.
Cholesterol plasma levels upon acute stress decreased 
in male rats and increased in female and ovariectomized 
rats (Table 1 and Figure 6). Cholesterol levels were high-
est in ovariectomized rats (median 3.15 mmol/L), followed 
by female (median 2.68 mmol/L) and male rats (median 
2.36 mmol/L; Table 1) upon acute stress. The difference 
in cholesterol levels upon acute stress between male and 
female rats was not signifi cant. However, the differences 
between male and ovariectomized and then female and 
ovariectomized rats upon acute stress were both statisti-
cally signifi cant (p=0.036 and p=0.018, respectively) with 
ovariectomized group having the highest values. The dif-
ferences in cholesterol levels between male, female and 
ovariectomized animal group upon chronic stress were all 
non-signifi cant.
Discussion
The results of this study demonstrate a signifi cant dif-
ference between tested groups in plasma glucose, uric acid 
and cholesterol levels upon acute stress. It is important to 
note that these differences were statistically signifi cant 
only upon acute stress; in chronic stress groups the differ-
ences were non-signifi cant for all measured parameters. 
Fig 5. Plasma uric acid values in all animal groups upon acute (A) and chronic stress (B). MAS – males acutely stressed, FAS – 
females acutely stressed, OAS – ovariectomized acutely stressed, MC – male controls, FC – female controls, OC – ovariectomized 
controls, MCS – males chronically stressed, FCS – females chronically stressed, OC – ovariectomized chronically stressed.
Fig. 6. Plasma cholesterol values in all animal groups upon acute (A) and chronic stress (B). MAS – males acutely stressed, FAS – 
females acutely stressed, OAS – ovariectomized acutely stressed, MC – male controls, FC – female controls, OC – ovariectomized 
controls, MCS – males chronically stressed, FCS – females chronically stressed, OC – ovariectomized chronically stressed. 
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Glucose plasma levels were higher in all groups at acute 
and chronic stress when compared to the fi rst measure-
ment during the GTT and can be explained as additional 
stress during the collection of the blood from the heart. 
Glucose plasma levels were lower in all chronic stress 
groups compared to the control group and upon acute 
stress the levels were highest in male rats, followed by 
ovariectomized and female rats. We found a signifi cant 
difference in glucose plasma levels between male and fe-
male rats upon acute stress, but no signifi cant difference 
was found between male and ovariectomized rats. These 
differences could be the consequence of mediation of acute 
stress response by sex hormones, since ovariectomized rats 
with lower estrogens levels respond more similarly to male 
than female rats. Estrogens play an important role in nu-
merous physiological functions41, including lipid metabo-
lism and infl ammatory response, which are both crucial 
for the development of atherosclerosis6. With this in mind, 
it is not surprising that estrogens defi ciency, whether in 
menopause42 or in premenopausal women43,44, has a delete-
rious effect on the development of cardiovascular disease. 
Since infl ammation is believed to have a role in the 
development of cardiovascular disease, measurement of 
CRP as a marker of infl ammation has been used as a 
method to improve the prediction of this risk37. CRP plas-
ma levels were lower in males upon acute stress when 
compared to control group. Also, CRP values were highest 
in males, with ovariectomized females a close second, par-
ticularly upon chronic stress. Similarly to the plasma glu-
cose concentrations, this might imply a connection be-
tween acute-phase proteins (such as CRP) and estrogens 
levels. In our study we did not fi nd statistically signifi cant 
differences in CRP values among groups, which could also 
imply that a longer, more intensive chronic stress protocol 
and perhaps a bigger sample size is needed to obtain ex-
pected results. 
In plasma measurements of uric acid levels – values 
were highest in male rats, followed by ovariectomized and 
female rats. We found a signifi cant difference between 
male and female rats upon acute stress, but the difference 
between male and ovariectomized rats remained non-
signifi cant, which also suggests sex hormone mediation of 
acute stress response. Uric acid is known as an oxidative 
stress biomarker. Low levels of uric acid are less common 
than high levels and could be linked with neurodegenera-
tive diseases. It has been postulated that a low uric acid 
level could translate into greater oxidative stress, since 
uric acid is a known antioxidant45. Hyperuricemia is also 
associated with risk for cardiovascular disease46. In our 
study we observed a signifi cant decrease in uric acid val-
ues upon acute stress in all groups (Table 1). Compared to 
acute stress groups’ values, uric acid values increased af-
ter chronic stress in female and ovariectomized rats, but 
decreased slightly in male rats. The differences in uric 
acid levels between acute stress groups were not signifi -
cant in male and ovariectomized rats, but we found a sig-
nifi cant difference between male and female rats. These 
results indicate that females react more promptly to acute 
stress and that a longer period of chronic stress is needed 
to produce the expected elevation in uric acid levels in 
male and ovariectomized rats. Since most cardiovascular 
diseases are chronic by nature, it is essential to determine 
the adequate time needed to yield results in future ex-
periments. Gender-related differences in uric acid levels 
were previously documented in rat models47, but not after 
acute and chronic stress exposure. Gender-related chang-
es in uric acid levels might be another factor modulated 
by the circulating sex hormone levels. 
Sexual dimorphism is also well documented in various 
mouse models of diabetes, but the exact mechanisms of 
pathogenesis remain elusive48–50. Elevated serum uric acid 
(hyperuricaemia) is also observed more frequently with 
the occurring epidemic of metabolic syndrome, diabetes 
and cardiovascular disease, and it is postulated that it 
might play a causal role in the pathogenesis of these ail-
ments51–53.
Cholesterol levels increased upon acute stress in both 
female and ovariectomized rats, while we observed a de-
crease in male rats. Ovariectomized rats had the highest 
cholesterol levels upon acute stress, signifi cantly higher 
than both female and male rats. After chronic stress the 
differences were all non-signifi cant. These fi ndings sug-
gest that the metabolic response to acute stress is affected 
by the estrogens defi ciency following ovariectomy. Basal 
levels of cholesterol were, as expected, higher in male rats. 
Conclusion 
We observed statistically signifi cant differences in 
plasma levels of glucose, uric acid and cholesterol in male, 
female and ovariectomized rats upon acute stress. We can 
conclude that female rats’ acute stress response in this 
experimental setting is different from the response of 
male rats and ovariectomized female rats, which suggests 
a role for sex hormone mediation. Gender-related differ-
ences were present in chronic stress response as well, but 
they were not substantial enough to achieve statistical 
signifi cance. Findings from this introductory study war-
rant further investigation, which is why we are currently 
working on involving other biochemical markers for oxida-
tive stress in cardiovascular pathology (malondialdehyde, 
glutathione peroxidase, super oxide dismutase, nitric ox-
ide synthase) in acute and chronic stress protocols.
There are two limitations to our study – the fi rst is a 
relatively small sample size, and the second is the time 
needed to produce biological changes in chronic stress pro-
tocol. While it is often diffi cult to increase sample size due 
to technical and ethical reasons, we see much room for 
improvement in the chronic stress protocol. In particular, 
the duration of stress exposure and the type of stressor 
could be improved to obtain maximal effect from the 
chronic stress protocol in the future. 
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SADRŽAJ GLUKOZE, C-REAKTIVNOG PROTEINA, MOKRAĆNE KISELINE I KOLESTEROLA U 
PLAZMI MUŽJAKA, ŽENKI, TE OVARIEKTOMIZIRANIH ŠTAKORA POD UTJECAJEM AKUTNOG I 
KRONIČNOG STRESA – PUT ZA RAZVOJ KARDIOVASKULARNIH BOLESTI
S A Ž E T A K
Kako bismo istražili razlike kardiovaskularne funkcije pod utjecajem stresa između spolova, analizirali smo razine 
glukoze, C-reaktivnog proteina (CRP), mokraćne kiseline, te kolesterola u plazmi mužjaka, ženki i ovariektomiziranih 
štakora pod utjecajem akutnog i kroničnog stresa. Također smo izveli test tolerancije na glukozu (GTT) na svim štakorima 
prije stresnog tretmana, te nakon kroničnog stresa.  GTT kontrolnih životinja pokazuje isti obrazac kao i životinje koje 
su podvrgnute kroničnom stresu. U usporedbi s ostale dvije grupe mužjaci pokazuju najviše vrijednosti glukoze i mokraćne 
kiseline u plazmi nakon akutnog stresa. Ovariektomizirana grupa pokazuje najviše vrijednosti kolesterola u plazmi pod 
utjecajem akutnog i kroničnog stresa, te također najviše vrijednosti CRP-a pri akutnom stresu. Stres kao rizični faktor 
metaboličkog sindroma, utječe na biokemijske parametre u mužjaka više pod akutnim, nego kroničnim stresom, no 
suprotno vrijedi za grupu ženki. Razlike između spolova, a posebno pri ovariektomiji pokazuju kako bi podnošenje 
stresa moglo biti pod utjecajem spolnih hormona.
